EMBARC3: Validation Of A Pseudomonas Elastase As A Therapeutic Target

Chalmers, James (Investigator)

Respiratory Medicine and Gastroenterology

Status	Active
Effective start/end date	1/08/23 → 31/01/25

Funding

LifeArc (Cha.002.094.003): £155,123.00

1 Article

Airway 'Resistotypes' and Clinical Outcomes in Bronchiectasis
Mac Aogáin, M., Xaverius Ivan, F., Jaggi, T. K., Richardson, H., Shoemark, A., Narayana, J. K., Dicker, A. J., Koh, M. S., Lee, K. C. H., Thun How, O., Poh, M. E., Chin, K. K., Hou, A. L. Y., Ser Hon, P., Low, T. B., Abisheganaden, J. A., Dimakou, K., Digalaki, A., Kosti, C. & Gkousiou, A. & 5 others, Hansbro, P. M., Blasi, F., Aliberti, S., Chalmers, J. D. & Chotirmall, S. H. (Lead / Corresponding author), 24 Jan 2024, (E-pub ahead of print) In: American Journal of Respiratory and Critical Care Medicine. 79 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
8 Citations (Scopus)

87 Downloads (Pure)